New tool may benefit frail patients in multi-hospital health systems

Frail patients in private-sector, multi-hospital health systems may benefit from a tool that can quickly predict their risk for poor outcomes following surgery, including postoperative mortality, readmission and extended hospital stays.

New research from UPMC -- published recently in the Annals of Surgery -- demonstrated that this prospective assessment index, which was previously validated in the VA Health System, was effectively implemented at scale in UPMC's diverse environment, requiring only 30 seconds per patient to accurately stratify patients for frailty.

Initially developed by the VA eight years ago, the so-called Risk Analysis Index (RAI) has been shown to accurately classify a patient's frailty and to predict their risk for adverse health consequences following surgery and other procedures. Until now, however, questions remained about the feasibility of implementing the index within complex, multi-hospital systems and the validity of the scores in a non-veteran population.

Previous studies have shown that frail patients are at higher risk for poor outcomes after surgery, and our recent research shows that even procedures that physicians typically consider 'low risk' result in a higher rate of adverse events for frail patients. We want to ensure that all patients have the best outcomes possible based on their unique health factors. Validating the RAI in UPMC's large-scale clinical environment is a step toward that goal and provides a roadmap for other health systems."

Daniel Hall, M.D., corresponding author of the study and associate professor of surgery, University of Pittsburgh School of Medicine

The RAI uses a variety of clinical and patient-reported factors, such as age, gender, appetite, chronic health conditions and daily activity levels to generate a score representing each patient's level of frailty. Hall and his team implemented the RAI as a patient-facing questionnaire, integrating the tool into the electronic health record at UPMC surgical practices in Pittsburgh.

From July 1 to Dec. 31, 2016, 42,738 RAI assessments were completed for 36,261 patients across five surgical clinics -- or 77% of eligible patients within the first six months. Among this sample and compared to patients with "normal" RAI scores, patients considered "very frail" suffered five times the rate of death, three times the rate of readmission and 10 times the rate of extended hospital stays.

"This represents the largest reported cohort of patients with prospectively measured frailty within a clinical setting," said Hall, who also is medical director of the Wolff Center at UPMC, the health system's multi-disciplinary quality improvement center.

More importantly, he noted, his team demonstrated that the RAI has value as a broad screening instrument -- regardless of the patient's gender -- because it does not require the dedicated expertise of specific providers, disruption to the clinical workflow or additional clinic time beyond the initial surgical visit.

"With the silver tsunami of aging boomers, accurate and rapid risk stratification will be increasingly essential to ensure that surgical treatment is offered to the right patients and consistent with older patients' goals and values," said Hall. "Clinicians worried about the burden of frailty assessment used to ask, 'How can I afford to measure frailty?' However, these data demand a different question: 'How can I afford NOT to measure frailty?"

Further study is needed to show that interventions based on this information translate to improved outcomes or lower costs.

Source:
Journal reference:

Varley, P.R., et al. (2020) Clinical Utility of the Risk Analysis Index as a Prospective Frailty Screening Tool within a Multi-practice, Multi-hospital Integrated Healthcare System. Annals of Surgery. doi.org/10.1097/SLA.0000000000003808.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy